The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2, Supplement 2 , Pages S24-S32, February 2010

Innate immunity

  • Stuart E. Turvey, MB, BS, DPhil

      Affiliations

    • Department of Paediatrics, BC Children's Hospital and Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada
    • Corresponding Author InformationReprint requests: Stuart Turvey, MB, BS, DPhil, FRCPC, Division of Infectious and Immunological Diseases, BC Children's Hospital and Child & Family Research Institute, University of British Columbia, 950 West 28 Ave, Vancouver BC V5Z 4H4, Canada.
  • ,
  • David H. Broide, MB, ChB

      Affiliations

    • Department of Medicine, University of California San Diego, La Jolla, Calif

Received 14 May 2009; received in revised form 3 July 2009; accepted 8 July 2009. published online 25 November 2009.

Recent years have witnessed an explosion of interest in the innate immune system. Questions about how the innate immune system senses infection and empowers a protective immune response are being answered at the molecular level. These basic science discoveries are being translated into a more complete understanding of the central role innate immunity plays in the pathogenesis of many human infectious and inflammatory diseases. It is particularly exciting that we are already seeing a return on these scientific investments with the emergence of novel therapies to harness the power of the innate immune system. In this review we explore the defining characteristics of the innate immune system, and through more detailed examples, we highlight recent breakthroughs that have advanced our understanding of the role of innate immunity in human health and disease.

Key words: Host defense, innate immunity, Toll-like receptors, nucleotide oligomerization domain–like receptors

Abbreviations used: DAMP, Damage-associated molecular pattern, IPAF, IL-1β-converting enzyme (ICE) protease-activating factor, IRAK4, IL-1 receptor–associated kinase 4, MAL, MyD88 adapter-like, MPL, Monophosphoryl lipid A, MyD88, Myeloid differentiation primary response gene 88, NK, Natural killer, NLR, Nucleotide oligomerization domain–like receptor, NLRP3, NLR family, pyrin domain-containing 3, NOD, Nucleotide oligomerization domain, SNP, Single nucleotide polymorphism, TIR, Toll/IL-1 receptor–like domain, TIRAP, Toll/IL-1 receptor–like domain–containing adaptor protein, TLR, Toll-like receptor

 

 S. E. T. is supported by a Chaim Roifman Scholar Award from the Canadian Immunodeficiency Society and a Career Development Award from the Canadian Child Health Clinician Scientist Program (CCHCSP)-a CIHR Strategic Training Program and operating grants from the Canadian Cystic Fibrosis Foundation and the CIHR Team in Mutagenesis and Infectious Diseases. D.H.B. is supported by NIH grants AI 038425, AI072115 and AI070535.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01083-5

doi:10.1016/j.jaci.2009.07.016

Refers to article:

  • Innate immunity

    The Journal of Allergy and Clinical Immunology February 2010 (Vol. 125, Issue 2, Supplement 2, Page S346)

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2, Supplement 2 , Pages S24-S32, February 2010